Evidence map›Paper›PMID 35840679›Full record

ArticleNature chemical biology2022

Author Correction: Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target.

Severin Lechner, Martin Ian P Malgapo, Christian Grätz, Raphael R Steimbach, Agnes Baron, Patrick Rüther, Simon Nadal, Carmen Stumpf, Christina Loos, Xin Ku and 15 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Severin LechnerChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0003-2297-9208
Martin Ian P MalgapoDepartment of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Christian GrätzAnimal Physiology and Immunology, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-9356-7940
Raphael R SteimbachCancer Drug Development, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-5509-3959
Agnes BaronChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Patrick RütherChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0003-4461-9828
Simon NadalChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-0748-0284
Carmen StumpfChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Christina LoosChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Xin KuChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Polina ProkofevaChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Ludwig LautenbacherComputational Mass Spectrometry, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-1540-5911
Tino HeimburgInstitute of Pharmacy, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany.
Vivian WürfLipiTUM, Chair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0001-5585-5936
Chen MengBavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich, Freising, Germany.
Mathias WilhelmComputational Mass Spectrometry, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-9224-3258
Wolfgang SipplInstitute of Pharmacy, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany.ORCID http://orcid.org/0000-0002-5985-9261
Karin KleigreweBavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich, Freising, Germany.
Josch K PaulingLipiTUM, Chair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Karl KramerChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Aubry K MillerCancer Drug Development, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Michael W PfafflAnimal Physiology and Immunology, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.
Maurine E LinderDepartment of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID http://orcid.org/0000-0003-2202-9712
Bernhard KusterChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany.ORCID http://orcid.org/0000-0002-9094-1677
Guillaume MédardChair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Germany. g.medard@tum.de.ORCID http://orcid.org/0000-0002-4782-4029

Funding

Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) GM121540
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35840679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.